J Clin Invest. 2021 Aug 2;131(15). doi: 10.1172/JCI150473.
The healthy lung was long thought of as sterile, but recent advances using molecular sequencing approaches have detected bacteria at low levels. Healthy lung bacteria largely reflect communities present in the upper respiratory tract that enter the lung via microaspiration, which is balanced by mechanical and immune clearance and likely involves limited local replication. The nature and dynamics of the lung microbiome, therefore, differ from those of ecological niches with robust self-sustaining microbial communities. Aberrant populations (dysbiosis) have been demonstrated in many pulmonary diseases not traditionally considered microbial in origin, and potential pathways of microbe-host crosstalk are emerging. The question now is whether and how dysbiotic microbiota contribute to initiation or perpetuation of injury. The fungal microbiome and virome are less well studied. This Review highlights features of the lung microbiome, unique considerations in studying it, examples of dysbiosis in selected disease, emerging concepts in lung microbiome-host interactions, and critical areas for investigation.
长期以来,人们一直认为健康的肺部是无菌的,但最近使用分子测序方法的进展已经检测到低水平的细菌。健康肺部的细菌在很大程度上反映了存在于上呼吸道中的群落,它们通过微吸入进入肺部,微吸入通过机械和免疫清除来平衡,并且可能涉及有限的局部复制。因此,肺部微生物组的性质和动态与具有强大自我维持微生物群落的生态位不同。在许多传统上不被认为起源于微生物的肺部疾病中已经证明存在异常菌群(生态失调),并且微生物-宿主相互作用的潜在途径正在出现。现在的问题是,失调的微生物组是否以及如何导致损伤的发生或持续。真菌微生物组和病毒组的研究则较少。这篇综述强调了肺部微生物组的特征、研究肺部微生物组时的独特考虑因素、特定疾病中生态失调的实例、肺部微生物组-宿主相互作用中的新兴概念以及需要研究的关键领域。
J Clin Invest. 2021-8-2
Front Microbiol. 2015-2-13
Int J Mol Sci. 2020-4-11
J Heart Lung Transplant. 2021-8
Semin Respir Crit Care Med. 2018-3-26
Microbiol Spectr. 2023-2-14
Front Endocrinol (Lausanne). 2022
Am J Respir Cell Mol Biol. 2023-3
Diagnostics (Basel). 2025-6-4
Front Cell Infect Microbiol. 2025-5-27
Mol Med. 2025-5-23
Front Cell Infect Microbiol. 2025-4-22
Microb Biotechnol. 2025-5
Microorganisms. 2025-4-20
NPJ Biofilms Microbiomes. 2021-2-5
Cochrane Database Syst Rev. 2021-1-15
CA Cancer J Clin. 2021-1